Symbol
MYGN on Nasdaq
Investment type
Equity / Common Stock, par value $0.01 per share
Latest Disclosed Shares Owned
3,939,238 shares
Security Ownership %
4.2%
Shares, Excluding Options vs Price
Value, Excluding Options

Barclays PLC ownership in MYRIAD GENETICS INC Common Stock, par value $0.01 per share (MYGN)

12 Nov 2025 - Barclays PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,939,238 shares of MYRIAD GENETICS INC Common Stock, par value $0.01 per share (MYGN). This represents 4.2% ownership of the company. In their previous filing dated 12 Aug 2025, BARCLAYS PLC had reported owning 4,899,951 shares, indicating a decrease of +20%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.